Companies: 10,795·Total market cap: $144.5T
Tekla Life Sciences Investors

Tekla Life Sciences Investors

HQLNYSEFinancial Services● Active
$16.67
$-0.25(-1.48%)
Market Cap$506901360
P/E Ratio
52W High$18.46
52W Low$12.34
Overview

Tekla Life Sciences Investors(HQL)· 资产负债表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · HQL · 截至 2026-06-10

财务报表

Total Assets · Total Liabilities · Equity
Breakdown2025-092024-092023-092022-092021-09
Assets
Cash & ST Investments$0.08M$0.00M$15.24M$0.00M$0.00M
Net Receivables$1.14M$0.23M$5.04M$0.62M$0.15M
Inventory$0.00M$0.00M$0.00M$0.00M$0.00M
Total Current Assets$1.25M$0.28M$5.05M$0.62M$0.14M
PP&E Net$0.00M$0.00M$0.00M$0.00M$0.00M
Goodwill$0.00M$0.00M$0.00M$0.00M$0.00M
Intangible Assets$0.00M$0.00M$0.00M$0.00M$0.00M
Total Assets$515.38M$460.58M$402.60M$414.73M$534.19M
Liabilities
Short-Term Debt$0.00M$0.00M$0.00M$11.09M$10.04M
Accounts Payable$0.72M$0.00M$0.00M$5.10M$0.15M
Total Current Liabilities$0.72M$0.89M$0.00M$5.10M$10.75M
Long-Term Debt$0.00M$0.00M$0.00M$0.00M$0.00M
Total Liabilities$1.73M$0.89M$0.67M$16.82M$10.75M
Stockholders Equity
Retained Earnings$77.60M$44.13M($1.48M)$9.55M$150.70M
Total Stockholders Equity$513.66M$459.69M$401.93M$397.90M$523.44M
Total Liab & Equity(computed)$515.38M$460.58M$402.60M$414.73M$534.19M
Debt Summary
Total Debt$0.00M$0.00M$0.00M$11.09M$1.34M
Net Debt($0.08M)$0.00M($0.00M)$0.01M$1.34M

数据来源:Financial Modeling Prep · 最后更新:2026-06-10 · USD · M

深入了解Tekla Life Sciences Investors

关于Tekla Life Sciences Investors(HQL)资产负债表

Tekla Life Sciences Investors总资产$0.52B,现金及短期投资$0.00B,总负债$0.00B,总债务$0.00B,股东权益$0.51B。

常见问题

HQL · 4 问

Tekla Life Sciences Investors总债务$0.00B,净债务($0.00B)。

HQL total debtnet debtdebt to equity

· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10